PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
IMVT vs. XMMO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

IMVT vs. XMMO

Last updated Aug 1, 2026
Documentation

IMVT (Immunovant, Inc.) is a stock, while XMMO (Invesco S&P MidCap Momentum ETF) is Momentum fund tracking the S&P MidCap 400 Momentum Index. Over the past 5 years, IMVT returned 29.85%/yr vs 13.41%/yr for XMMO. Their 0.34 correlation means their historical movements had little consistent relationship.

Performance

IMVT vs. XMMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immunovant, Inc. (IMVT) and Invesco S&P MidCap Momentum ETF (XMMO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IMVT achieves a 51.93% return, which is significantly higher than XMMO's 11.79% return.

IMVT

1D
-2.18%
1M
-0.44%
6M
48.54%
YTD
51.93%
1Y
145.83%
3Y*
18.74%
5Y*
29.85%
10Y*
—
ALL TIME*
16.27%

XMMO

1D
0.22%
1M
-5.42%
6M
10.34%
YTD
11.79%
1Y
20.56%
3Y*
23.81%
5Y*
13.41%
10Y*
18.04%
ALL TIME*
12.11%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)

IMVT

Immunovant, Inc.
$35.51M$39.13M$60.17M

XMMO

Invesco S&P MidCap Momentum ETF
$60.32M$71.93M$66.65M

IMVT vs. XMMO - Yearly Performance Comparison

2026 (YTD)2025202420232022202120202019
IMVT
Immunovant, Inc.		51.93%2.62%-41.21%137.35%108.33%-81.55%191.05%11.37%
XMMO
Invesco S&P MidCap Momentum ETF		11.79%13.04%38.03%20.39%-16.02%16.69%29.17%1.85%

Correlation

The correlation between IMVT and XMMO is 0.32, which is low. Their historical price movements had little consistent relationship.

Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.32

Correlation (3Y)
Balances recent behavior with more history.

0.31

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.33

Correlation (All Time)
Calculated using the full available price history since Dec 19, 2019

0.34

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Immunovant, Inc.

Invesco S&P MidCap Momentum ETF

Often compared with IMVT:
IMVT vs. MDGLIMVT vs. IRWDIMVT vs. SMHIMVT vs. VOOIMVT vs. NDAQIMVT vs. XBIIMVT vs. TLT
Often compared with XMMO:
XMMO vs. SPMOXMMO vs. VOOXMMO vs. XMHQXMMO vs. MTUMXMMO vs. QMOMXMMO vs. FMTMXMMO vs. XSMO

Return for Risk

IMVT vs. XMMO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.
IMVT
IMVT Risk / Return Rank: 9696
Overall Rank
IMVT Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IMVT Sortino Ratio Rank: 9696
Sortino Ratio Rank
IMVT Omega Ratio Rank: 9292
Omega Ratio Rank
IMVT Calmar Ratio Rank: 9898
Calmar Ratio Rank
IMVT Martin Ratio Rank: 9898
Martin Ratio Rank
XMMO
XMMO Risk / Return Rank: 3939
Overall Rank
XMMO Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
XMMO Sortino Ratio Rank: 3636
Sortino Ratio Rank
XMMO Omega Ratio Rank: 3535
Omega Ratio Rank
XMMO Calmar Ratio Rank: 3939
Calmar Ratio Rank
XMMO Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IMVT vs. XMMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Invesco S&P MidCap Momentum ETF (XMMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

IMVTXMMODifference
Sharpe ratioReturn per unit of total volatility
2.29
0.89

+1.39

Sortino ratioReturn per unit of downside risk
3.67
1.35

+2.32

Omega ratioGain probability vs. loss probability

1.40

1.17

+0.23

Calmar ratioReturn relative to maximum drawdown

8.20

1.38

+6.82

Martin ratioReturn relative to average drawdown

21.37

5.81

+15.55

IMVT vs. XMMO - Sharpe Ratio Comparison

The current IMVT Sharpe Ratio is 2.29, which is higher than the XMMO Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of IMVT and XMMO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

IMVT vs. XMMO - Drawdown Comparison

The maximum IMVT drawdown since its inception was -93.59%, which is greater than XMMO's maximum drawdown of -55.37%. Use the drawdown chart below to compare losses from any high point for IMVT and XMMO.

Loading charts...

Drawdown Indicators

IMVTXMMODifference

Max Drawdown

Largest peak-to-trough decline

-93.59%

-55.37%

-38.22%

Max Drawdown (1Y)

Largest decline over 1 year

-17.19%

-13.91%

-3.28%

Max Drawdown (3Y)

Largest decline over 3 years

-69.88%

-24.93%

-44.95%

Max Drawdown (5Y)

Largest decline over 5 years

-69.88%

-27.91%

-41.97%

Max Drawdown (10Y)

Largest decline over 10 years

—

-36.74%

—

Current Drawdown

Current decline from peak

-26.73%

-11.24%

-15.49%

Average Drawdown

Average peak-to-trough decline

-53.37%

-9.42%

-43.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.59%

3.29%

+3.30%

Volatility

IMVT vs. XMMO - Volatility Comparison

Immunovant, Inc. (IMVT) has a higher volatility of 9.73% compared to Invesco S&P MidCap Momentum ETF (XMMO) at 7.88%. This indicates that IMVT's price experiences larger fluctuations and is considered to be riskier than XMMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

IMVTXMMODifference

Volatility (1M)

Calculated over the trailing 1-month period

9.73%

7.88%

+1.85%

Volatility (6M)

Calculated over the trailing 6-month period

44.56%

18.46%

+26.10%

Volatility (1Y)

Calculated over the trailing 1-year period

61.81%

21.50%

+40.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.72%

21.86%

+52.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.70%

22.43%

+55.27%

Dividends

IMVT vs. XMMO - Dividend Comparison

IMVT has not paid dividends to shareholders, while XMMO's dividend yield for the trailing twelve months is around 0.63%.

PositionTTM20252024202320222021202020192018201720162015
IMVT
Immunovant, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XMMO
Invesco S&P MidCap Momentum ETF		0.63%0.78%0.34%0.80%1.43%0.41%0.61%0.60%0.19%0.21%0.22%0.64%

Frequently Asked Questions

IMVT and XMMO have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IMVT has higher volatility (9.73%) compared to XMMO (7.88%). In terms of maximum drawdown, IMVT dropped -93.59% vs XMMO's -55.37%.

IMVT currently has the higher Sharpe Ratio (2.29 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IMVT and XMMO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer